This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jun;187(2):235-9.

doi: 10.1016/j.expneurol.2004.02.008.

Following the leader: fibrillization of alpha-synuclein and tau

Mark Frasier¹, Benjamin Wolozin

Affiliations

PMID: 15144849
DOI: 10.1016/j.expneurol.2004.02.008

Review

Following the leader: fibrillization of alpha-synuclein and tau

Mark Frasier et al. Exp Neurol. 2004 Jun.

. 2004 Jun;187(2):235-9.

doi: 10.1016/j.expneurol.2004.02.008.

Authors

Mark Frasier¹, Benjamin Wolozin

Affiliation

¹ Department of Pharmacology, Loyola University Medical Center, Maywood, IL 60153, USA.

PMID: 15144849
DOI: 10.1016/j.expneurol.2004.02.008

No abstract available

PubMed Disclaimer

Similar articles

alpha-Synuclein: a potent inducer of tau pathology.
Geddes JW. Geddes JW. Exp Neurol. 2005 Apr;192(2):244-50. doi: 10.1016/j.expneurol.2004.12.002. Exp Neurol. 2005. PMID: 15755542 Review. No abstract available.
From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, Jakes R, Crowther RA. Goedert M, et al. Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):213-27. doi: 10.1098/rstb.2000.0767. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11260802 Free PMC article. Review.
Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM. Kotzbauer PT, et al. Exp Neurol. 2004 Jun;187(2):279-88. doi: 10.1016/j.expneurol.2004.01.007. Exp Neurol. 2004. PMID: 15144854
Initiation and synergistic fibrillization of tau and alpha-synuclein.
Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM. Giasson BI, et al. Science. 2003 Apr 25;300(5619):636-40. doi: 10.1126/science.1082324. Science. 2003. PMID: 12714745
More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM, Giasson BI, Trojanowski JQ. Lee VM, et al. Trends Neurosci. 2004 Mar;27(3):129-34. doi: 10.1016/j.tins.2004.01.007. Trends Neurosci. 2004. PMID: 15036877

See all similar articles

Cited by

Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.
Chu Y, Hirst WD, Federoff HJ, Harms AS, Stoessl AJ, Kordower JH. Chu Y, et al. Brain. 2024 Feb 1;147(2):444-457. doi: 10.1093/brain/awad388. Brain. 2024. PMID: 38006313 Free PMC article.
Recent advances in our understanding of neurodegeneration.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2009 Sep;116(9):1111-62. doi: 10.1007/s00702-009-0240-y. Epub 2009 Jun 5. J Neural Transm (Vienna). 2009. PMID: 19707851 Review.
Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.
Phillips RJ, Walter GC, Ringer BE, Higgs KM, Powley TL. Phillips RJ, et al. Exp Neurol. 2009 Nov;220(1):109-19. doi: 10.1016/j.expneurol.2009.07.025. Epub 2009 Aug 5. Exp Neurol. 2009. PMID: 19664623 Free PMC article.
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.
Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K. Noble W, et al. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6990-5. doi: 10.1073/pnas.0500466102. Epub 2005 May 2. Proc Natl Acad Sci U S A. 2005. PMID: 15867159 Free PMC article.
Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
Duka T, Duka V, Joyce JN, Sidhu A. Duka T, et al. FASEB J. 2009 Sep;23(9):2820-30. doi: 10.1096/fj.08-120410. Epub 2009 Apr 15. FASEB J. 2009. PMID: 19369384 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Miscellaneous
- NCI CPTAC Assay Portal